March 12, 2020 / 7:42 AM / a month ago

BRIEF-Biovica International: Positive Result From Swedish Study With DiviTum

March 12 (Reuters) - Biovica International AB:

* POSITIVE RESULT FROM SWEDISH STUDY WITH DIVITUM

* DIVITUM BLOOD TEST CAN BE USED AS PROGNOSTIC TOOL FOR EVALUATING TREATMENT OUTCOMES FOR WIDESPREADBREAST CANCER Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below